REHOVOT, Israel, May 17, 2017 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading company for the improvement of crop productivity and economics for food, feed and fuel, announced today its financial results for the first quarter ended March 31, 2017.
Ofer Haviv, Evogene’s President and CEO, stated: “Important progress continues in all three of our core business areas, Ag-Biologicals, Seed Traits and Ag-Chemicals. This progress includes an overall key corporate initiative to expand our capabilities and activities past the discovery phase and into early, and even advanced, product development phases. We expect our efforts will result in both new opportunities for various types of collaborations and the ability to obtain an increased share of future revenues from products based on our unique capabilities.